Navinta Llc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for NAVINTA LLC, and what generic and branded alternatives to NAVINTA LLC drugs are available?
NAVINTA LLC has sixteen approved drugs.
Summary for Navinta Llc
| US Patents: | 0 |
| Tradenames: | 15 |
| Ingredients: | 15 |
| NDAs: | 16 |
| Drug Master File Entries: | 25 |
Drugs and US Patents for Navinta Llc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Navinta Llc | SODIUM PHENYLACETATE AND SODIUM BENZOATE | sodium benzoate; sodium phenylacetate | SOLUTION;INTRAVENOUS | 205880-001 | Aug 4, 2016 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Navinta Llc | ROPIVACAINE HYDROCHLORIDE | ropivacaine hydrochloride | SOLUTION;INJECTION | 078601-003 | Jul 17, 2014 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Navinta Llc | FAMOTIDINE | famotidine | FOR SUSPENSION;ORAL | 091020-001 | May 27, 2010 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Navinta Llc | ROPIVACAINE HYDROCHLORIDE | ropivacaine hydrochloride | SOLUTION;INJECTION | 078601-002 | Jul 17, 2014 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Navinta Llc | BENZTROPINE MESYLATE | benztropine mesylate | INJECTABLE;INJECTION | 091525-001 | Feb 5, 2013 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
